First results of sotorasib plus pembrolizumab in KRAS p.G12C-mutated NSCLC Presented ByDr Bob Li, Memorial Sloan Kettering Cancer Center, NY, USA TrialPhase 1, CodeBreaK 100/101 ConferenceWCLC 2022 23 August, 2022 11:08